Login

Financial Snapshot

Revenue
TTM
$1.371B
Gross Margin
TTM
55.13%
Net Income
TTM
$54.85M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
229.09%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$1.018B
Cash
2026 Q1
P/E
TTM
18.15
Free Cash Flow
TTM
$123.7M

Stock Price

Loading...
Market Cap: $995.41 Million

About Conmed Corp

Conmed Corp (NASDAQ: CNMD) is a medical device company that develops, manufactures, and sells surgical equipment and related products. The filing excerpts provided do not contain sufficient detail to characterize its revenue model, segment breakdown, product lines, geographic footprint, competitive position, or leadership with the specificity required for a grounded description. Based solely on the available filing excerpts from the 10-K filed 2026-02-17 (accession 000081695626000009), no further factual claims can be supported.

Source: SEC 10-K, filed 2026-02-17

Industry: Electromedical & Electrotherapeutic Apparatus Peers: Abbott Laboratories AtriCure Inc Axonics, Inc. Enovis Corp Glaukos Corp Integer Holdings Corp Integra Lifesciences Holdings Corp iRhythm Holdings, Inc NUVASIVE INC Tandem Diabetes Care Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support